Whalesbook
Symbiox Investment & Trading Co. Ltd. announced on May 14, 2026, that its Board of Directors will convene on May 23, 2026. The meeting's primary agenda items are to consider and approve the audited financial results for the fiscal year ended March 31, 2026, and to review the Limited Review Report for that period. The board will also appoint the company's Secretarial and Internal Auditors for the upcoming fiscal year 2026-27.
The approval of audited financial results is a crucial step, providing shareholders with the definitive performance figures for FY26. The appointment of auditors for the next fiscal year confirms the continuation of essential statutory functions and ensures ongoing operational compliance.
Following the board meeting, shareholders can anticipate the formal disclosure of Symbiox Investment's audited financial results for FY26. This will offer insights into the company's financial health for the completed fiscal year, alongside the official confirmation of the appointed Secretarial and Internal Auditors for FY 2026-27.
Investors will be closely monitoring the specific numbers and commentary within the FY26 audited results and the Limited Review Report. Additionally, the formal announcement of the appointed auditors and the market's reaction to the released financial figures will be key points of focus moving forward.